These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 27749104)

  • 1. Adipokines: role in local and systemic inflammation of rheumatic diseases.
    Šenolt L
    Expert Rev Clin Immunol; 2017 Jan; 13(1):1-3. PubMed ID: 27749104
    [No Abstract]   [Full Text] [Related]  

  • 2. Beyond fat mass: exploring the role of adipokines in rheumatic diseases.
    Scotece M; Conde J; Gómez R; López V; Lago F; Gómez-Reino JJ; Gualillo O
    ScientificWorldJournal; 2011; 11():1932-47. PubMed ID: 22194660
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adipokines as potential pharmacological targets for immune inflammatory rheumatic diseases: Focus on rheumatoid arthritis, osteoarthritis, and intervertebral disc degeneration.
    Farrag Y; Farrag M; Varela-García M; Torrijos-Pulpón C; Capuozzo M; Ottaiano A; Lago F; Mera A; Pino J; Gualillo O
    Pharmacol Res; 2024 Jul; 205():107219. PubMed ID: 38763327
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Toll-like receptors and chronic inflammation in rheumatic diseases: new developments.
    Joosten LA; Abdollahi-Roodsaz S; Dinarello CA; O'Neill L; Netea MG
    Nat Rev Rheumatol; 2016 Jun; 12(6):344-57. PubMed ID: 27170508
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Moving towards a molecular taxonomy of autoimmune rheumatic diseases.
    Barturen G; Beretta L; Cervera R; Van Vollenhoven R; Alarcón-Riquelme ME
    Nat Rev Rheumatol; 2018 Jan; 14(2):75-93. PubMed ID: 29362467
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adipokines and inflammation: is it a question of weight?
    Francisco V; Pino J; Gonzalez-Gay MA; Mera A; Lago F; Gómez R; Mobasheri A; Gualillo O
    Br J Pharmacol; 2018 May; 175(10):1569-1579. PubMed ID: 29486050
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Review: Metabolic Regulation of Inflammation in Osteoarthritis.
    Berenbaum F; Griffin TM; Liu-Bryan R
    Arthritis Rheumatol; 2017 Jan; 69(1):9-21. PubMed ID: 27564539
    [No Abstract]   [Full Text] [Related]  

  • 8. Adipokines: novel players in rheumatic diseases.
    Conde J; Scotece M; López V; Gómez R; Lago F; Pino J; Gómez-Reino JJ; Gualillo O
    Discov Med; 2013 Feb; 15(81):73-83. PubMed ID: 23449109
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of adipokines in atherosclerosis: interferences with cardiovascular complications in rheumatic diseases.
    Scotece M; Conde J; Gómez R; López V; Pino J; González A; Lago F; Gómez-Reino JJ; Gualillo O
    Mediators Inflamm; 2012; 2012():125458. PubMed ID: 22910888
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Progranulin as a biomarker and potential therapeutic agent.
    Abella V; Pino J; Scotece M; Conde J; Lago F; Gonzalez-Gay MA; Mera A; Gómez R; Mobasheri A; Gualillo O
    Drug Discov Today; 2017 Oct; 22(10):1557-1564. PubMed ID: 28651064
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lymphocytes and macrophages in adipose tissue in obesity: markers or makers of subclinical inflammation?
    Cinkajzlová A; Mráz M; Haluzík M
    Protoplasma; 2017 May; 254(3):1219-1232. PubMed ID: 28150048
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Inflammatory rheumatism and fundamentals of its drug therapy].
    Borkenstein E
    Wien Med Wochenschr; 1971 May; 121(22):449-52. PubMed ID: 5314609
    [No Abstract]   [Full Text] [Related]  

  • 13. Adipokines in health and disease.
    Fasshauer M; Blüher M
    Trends Pharmacol Sci; 2015 Jul; 36(7):461-70. PubMed ID: 26022934
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adipokines as drug targets in joint and bone disease.
    Scotece M; Conde J; Vuolteenaho K; Koskinen A; López V; Gómez-Reino J; Lago F; Moilanen E; Gualillo O
    Drug Discov Today; 2014 Mar; 19(3):241-58. PubMed ID: 23906693
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adipose inflammation, insulin resistance, and cardiovascular disease.
    Shah A; Mehta N; Reilly MP
    JPEN J Parenter Enteral Nutr; 2008; 32(6):638-44. PubMed ID: 18974244
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inflammation, obesity, and the promise of immunotherapy for metabolic disease.
    O'Rourke RW
    Surg Obes Relat Dis; 2013; 9(5):609-16. PubMed ID: 22959472
    [No Abstract]   [Full Text] [Related]  

  • 17. Nanoparticle-based diagnostic imaging of inflammation in rheumatic disease.
    Rogers JL; Tarrant T; Kim JS
    Curr Rheumatol Rev; 2014; 10(1):3-10. PubMed ID: 25229498
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is obesity an adaptative response to inflammation?
    Ailhaud G
    Obes Rev; 2012 May; 13(5):480-1. PubMed ID: 22500727
    [No Abstract]   [Full Text] [Related]  

  • 19. The role of fat and inflammation in the pathogenesis and management of osteoarthritis.
    Urban H; Little CB
    Rheumatology (Oxford); 2018 May; 57(suppl_4):iv10-iv21. PubMed ID: 29444323
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The complement system as a potential therapeutic target in rheumatic disease.
    Trouw LA; Pickering MC; Blom AM
    Nat Rev Rheumatol; 2017 Sep; 13(9):538-547. PubMed ID: 28794515
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.